Skip to main content

Replimune Group, Inc. (REPL)

NASDAQ: REPL · IEX Real-Time Price · USD
28.62
+0.46 (1.63%)
Feb 7, 2023, 4:00 PM EST - Market closed

REPL Market Cap

Replimune Group has a market cap or net worth of $1.58 billion as of February 8, 2023. Replimune Group's market cap has increased by 44.33% in one year.

Market Cap
1.58B
Enterprise Value
1.24B
1-Year Change
44.33%
Ranking
#2160
Category
Small-Cap
Stock Price
$28.62

Market Cap Chart

Since July 20, 2018, Replimune Group, Inc.'s market cap has increased from $835.53M to $1.58B, an increase of 88.79%. That is a compound annual growth rate of 14.97%.

History

DateMarket Cap% Change
Feb 7, 20231.58B
1.63%
Feb 6, 20231.55B
-0.46%
Feb 3, 20231.56B
-2.75%
Feb 2, 20231.60B
1.75%
Feb 1, 20231.58B
2.66%
Jan 31, 20231.53B
7.82%
Jan 30, 20231.42B
-0.23%
Jan 27, 20231.43B
-0.92%
Jan 26, 20231.44B
-6.68%
Jan 25, 20231.54B
-2.71%
Jan 24, 20231.59B
4.58%
Jan 23, 20231.52B
0.33%
Jan 20, 20231.51B
0.55%
Jan 19, 20231.50B
-0.26%
Jan 18, 20231.51B
-1.55%
Jan 17, 20231.53B
-1.00%
Jan 13, 20231.55B
2.45%
Jan 12, 20231.51B
3.75%
Jan 11, 20231.46B
-0.86%
Jan 10, 20231.47B
4.47%
Jan 9, 20231.40B
-1.28%
Jan 6, 20231.42B
0.27%
Jan 5, 20231.42B
-1.90%
Jan 4, 20231.45B
-0.38%
Jan 3, 20231.45B
-3.13%
View and export this data all the way back to 2018. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Deciphera Pharmaceuticals, Inc. 1.27B
Cross Country Healthcare, Inc. 1.16B
uniQure N.V. 1.05B
POINT Biopharma Global, Inc. 838.82M
Editas Medicine, Inc. 774.27M
Theravance Biopharma, Inc. 717.45M
Erasca, Inc. 652.73M
Cardiovascular Systems, Inc. 616.51M
Design Therapeutics, Inc. 447.84M
Pulmonx Corporation 329.58M
Market Cap Rankings